Effects of reduction in heroin supply on injecting drug use: Analysis of data from needle and syringe programmes

British Medical Journal

Volumn 329, Issue 7463, 2004, Pages 428-429

  Day, Carolyn ^a   Degenhardt, Louisa ^a   Gilmour, Stuart ^a   Hall, Wayne ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; DATA ANALYSIS; DISEASE TRANSMISSION; DRUG USE; HEALTH PROGRAM; HEALTH SERVICE; HEPATITIS C; HUMAN; MATHEMATICAL MODEL; NEEDLE; PRIORITY JOURNAL; SYRINGE;

EID: 4344698249     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38201.410255.55     Document Type: Article

References (5)

1. Darke S, Topp L, Kaye S, Hall W. Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system (IDRS). Addiction 2002;97:179-86.
2. Topp L, Kaye S, Bruno R, Longo M, Williams P, O'Reilly B, et al. Australian drug trends 2001: findings from the illicit drug reporting system (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2002.
3. Degenhardt L, Day C, Hall W, eds. The causes, course and consequence of the heroin shortage in Australia. Adelaide: Australasian Centre for Policing Research, 2004.
4. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2003. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2003.
5. Law M, Dore G, Bath N, Thompson S, Crofts N, Dolan K, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717-24.